1. CAN BASELINE PET‐CT FEATURES PREDICT OUTCOMES IN ADVANCED HODGKIN LYMPHOMA? A PROSPECTIVE EVALUATION OF UK PATIENTS IN THE RATHL TRIAL (CRUK/07/033). (June 2017) Authors: Pike, L.C.; Kirkwood, A.A.; Patrick, P.; Radford, J.; Burton, C.; Stevens, L.; Clifton‐Hadley, L.; Johnson, P.W.; Barrington, S.F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY. (June 2017) Authors: Turaj, A.H.; Rose‐Zerilli, M.; Cox, K.; James, S.; Al‐Shamkhani, A.; Keler, T.; Johnson, P.W.; Thirdborough, S.M.; Beers, S.A.; Glennie, M.J.; Cragg, M.S.; Lim, S.H. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CROSS‐PLATFORM VALIDATION OF GENE EXPRESSION PROFILING (GEP) BASED CELL OF ORIGIN (COO) CLASSIFICATION IN a CLINICAL LABORATORY SETTING. (June 2017) Authors: Burton, C.; Barrans, S.; Ahmed, S.; Bentley, M.A.; Clipson, A.; Wang, M.; Taylor, J.; Detute, R.; Westhead, D.R.; Care, M.A.; Du, M.Q.; Davies, A.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B. (June 2017) Authors: Davies, A.J.; Barrans, S.; Maishman, T.; Cummin, T.E.; Bentley, M.; Mamot, C.; Novak, U.; Caddy, J.; Hamid, D.; Kazmi‐Stokes, S.H.; Mcmillan, A.; Fields, P.A.; Pocock, C.; Kruger, A.; Collins, G.; Sha, C.; Clipson, A.; Wang, M.; Tooze, R.M.; Care, M.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EARLY PROGRESSION OF DISEASE (POD24) PREDICTS SHORTER SURVIVAL IN MALT LYMPHOMA PATIENTS RECEIVING SYSTEMIC TREATMENT. (12th June 2019) Authors: Conconi, A.; Thieblemont, C.; Cascione, L.; Torri, V.; Kiesewetter, B.; Margiotta‐Casaluci, G.; Gaidano, G.; Raderer, M.; Cavalli, F.; Lopez Guillermo, A.; Johnson, P.W.; Zucca, E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. GENE EXPRESSION PROFILING AND MUTATION ANALYSIS CAN AID TREATMENT DECISION MAKING IN AGGRESSIVE B CELL LYMPHOMA PATIENTS. (June 2017) Authors: Burton, C.H.; Barrans, S.; Van Hoppe, S.; Sha, C.; Taylor, J.; Evans, P.; Painter, D.; Smith, A.; Crouch, S.; Goodlad, J.R.; Roman, E.; Westhead, D.; Davies, A.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identifying somatic mutations in cell‐free DNA of aggressive lymphoma patients: First cell‐free DNA results from the molecular profiling for lymphoma (MaPLe) study. (June 2017) Authors: Lopez Pascua, L.D.; Ahmed, S.M.; Barrans, S.; Burton, C.; Clipson, A.J.; Cucco, F.; Cutts, A.; Dreau, H.; Du, M.; Joke, D.; Mizani, R.T.; Salminen, O.; Van Hoppe, M.; Vaughan‐Spickers, N.; Schuh, A.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. METABOLIC HETEROGENEITY OF BASELINE 18‐FDG PET‐CT SCAN PREDICTS OUTCOME IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA. (June 2017) Authors: Ceriani, L.; Milan, L.; Martelli, M.; Ferreri, A.J.; Di Rocco, A.; Giovanella, L.; Cavalli, F.; Johnson, P.W.; Zucca, E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OUTCOMES OF TREATMENT FOR OBESE PATIENTS WITH ADVANCED HODGKIN LYMPHOMA IN THE RATHL TRIAL (CRUK/07/033). (June 2017) Authors: Preston, A.; Kirkwood, A.; Federico, M.; Trotman, J.; Fossa, A.; Stevens, L.; Clifton‐Hadley, L.; Patrick, P.; Berkahn, L.; d'Amore, F.; Enblad, G.; Luminari, S.; Radford, J.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PROGNOSTIC SIGNIFICANCE AND CORRELATION TO GENE EXPRESSION PROFILE OF EZH2 MUTATIONS IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL) IN 2 LARGE PROSPECTIVE STUDIES. (June 2017) Authors: Cummin, T.E.; Araf, S.; Du, M.; Barrans, S.; Bentley, M.A.; Clipson, A.; Wang, M.; Ahmed, S.; Rahim, T.; Shah, C.; Hamid, D.; Dhondt, J.; Maishman, T.; Vaughan‐Spickers, N.; Pocock, C.; Forbes, A.; O'Callaghan, A.; Westhead, D.; Griffiths, G.O.; Fitzgibbon, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗